C07D 303/17
Containing oxirane rings condensed with carbocyclic ring systems having three or more
Official title: containing oxirane rings condensed with carbocyclic ring systems having three or more relevant rings
C07D303/17 (Containing oxirane rings condensed with carbocyclic ring systems having three or more) appears on 13 US grants and 17 published applications in this corpus.
Search patents in C07D- Granted patents
- 13
- Published applications
- 17
- Assignees
- 11
- Inventors
- 36
- Latest grant
- 28 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 2 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 2 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Tiglien-3-one derivatives28 Jan 2025US 12,208,078 B2Qbiotics Pty Ltd
- Tiglien-3-one derivatives20 Apr 2021US 10,980,769 B2Qbiotics Pty Ltd
- Tiglien-3-one derivatives28 Jan 2020US 10,543,188 B2Qbiotics Pty Ltd
- Renewable modified natural compounds7 Nov 2017US 9,809,538 B2ISP Investments Inc.
- Tiglien-3-one derivatives26 Sep 2017US 9,770,431 B2QBiotics Limited
- Tiglien-3-one derivatives28 Sep 2023US 2023/0301960 A1Qbiotics Pty Ltd
- Alicyclic acrylate compound, alicyclic epoxy acrylate compound, curable composition, and cured product26 Jan 2023US 2023/0023687 A1Eneos Corporation
- Tiglien-3-one derivatives1 Jul 2021US 2021/0196668 A1Qbiotics Pty Ltd
- Tiglien-3-one derivatives11 Jun 2020US 2020/0179325 A1Qbiotics Pty Ltd
- Tiglien-3-one derivatives4 Apr 2019US 2019/0099397 A1QBiotics Limited
Most cited
By later US patents
- Oxiranyl ester derivatives as additive for electrolytes in lithium ion batteries5US 9,640,839 B2BASF SE · 2017
- Tiglien-3-one derivatives3US 8,598,229 B2QBiotics Limited · 2013
- Tiglien-3-one derivatives2US 10,543,188 B2Qbiotics Pty Ltd · 2020
- Tiglien-3-one derivatives2US 9,770,431 B2QBiotics Limited · 2017
- Tiglien-3-one derivatives1US 10,980,769 B2Qbiotics Pty Ltd · 2021